These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16011115)

  • 1. [A test system of prenatal screen for Down's syndrome].
    Jiang JP; Du M; Huang XY
    Zhongguo Yi Liao Qi Xie Za Zhi; 2005 Mar; 29(2):109-11. PubMed ID: 16011115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down's syndrome risk estimates demonstrate considerable heterogeneity despite homogeneity of input.
    Reynolds T; Ellis A; Jones R
    Ann Clin Biochem; 2004 Nov; 41(Pt 6):464-8. PubMed ID: 15588435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk estimation in Down's syndrome screening.
    Wald NJ; Hackshaw AK
    Prenat Diagn; 1996 Nov; 16(11):1055-7. PubMed ID: 8953642
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence rate of Down's syndrome in Karachi resident women.
    Rahman S; Obaid-ur-Rahman M
    Pak J Pharm Sci; 2005 Apr; 18(2):61-3. PubMed ID: 16431402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Down's syndrome screening population data sets by simulation: analyser-specific parameters may be superior to meta-analysis-derived parameters.
    Reynolds TM; Vranken G; Van Nueten J; Aldis J
    Int J Clin Pract; 2008 May; 62(5):735-43. PubMed ID: 17590221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Median parameters for Down's syndrome screening should be calculated using a moving time-window method.
    Reynolds TM; Aldis J
    Ann Clin Biochem; 2008 Nov; 45(Pt 6):567-70. PubMed ID: 18768535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trisomy 18 fetuses with cystic hygroma linked to positive maternal serum Down's syndrome Triple test screening result.
    Celentano C; Guanciali-Franchi PE; Liberati M; Prefumo F; Palka G; Rotmensch S
    J Med Screen; 2005; 12(4):203. PubMed ID: 16417699
    [No Abstract]   [Full Text] [Related]  

  • 9. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening.
    Leporrier N; Herrou M; Morello R; Leymarie P
    BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple-marker screening for Down's syndrome: a method of assessing the statistical robustness of proposed tests.
    Morris JK; Bestwick J; Wald NJ
    J Med Screen; 2008; 15(2):55-61. PubMed ID: 18573771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal screening for Down's syndrome.
    BMJ; 1991 Sep; 303(6804):715-6. PubMed ID: 1833015
    [No Abstract]   [Full Text] [Related]  

  • 12. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prenatal investigations for Down's syndrome: medical-technical considerations and dilemmas arising from current screening methods].
    Grijseels EW; Laudy JA; Galjaard RJ; Wildschut HI
    Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2166-71. PubMed ID: 15559409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Nicolaides' risk evaluation for Down's syndrome with a novel software: an analysis of 1,463 cases.
    Schmidt P; Staboulidou I; Soergel P; Wüstemann M; Hillemanns P; Scharf A
    Arch Gynecol Obstet; 2007 Jun; 275(6):469-74. PubMed ID: 17333228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal Down's screening test associated with severe hyperemesis gravidarum.
    Pradhan P; Mohajer M
    J Obstet Gynaecol; 2002 Nov; 22(6):692. PubMed ID: 12554274
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level.
    Br J Obstet Gynaecol; 1987 Dec; 94(12):1225-8. PubMed ID: 2447934
    [No Abstract]   [Full Text] [Related]  

  • 17. [Specificity of biochemical markers of pregnancy second trimester].
    Salazar López R; Ibarra Gallardo AL; Iduma Meléndrez M; Leyva Bojórquez R
    Ginecol Obstet Mex; 2007 Oct; 75(10):608-14. PubMed ID: 18800579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects.
    Jaques AM; Collins VR; Haynes K; Sheffield LJ; Francis I; Forbes R; Halliday JL
    J Med Screen; 2006; 13(1):8-13. PubMed ID: 16569299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk prediction for Down's syndrome in young pregnant women using maternal serum biomarkers: determination of cut-off risk from receiver operating characteristic curve analysis.
    Hwa HL; Ko TM; Hsieh FJ; Yen MF; Chou KP; Chen TH
    J Eval Clin Pract; 2007 Apr; 13(2):254-8. PubMed ID: 17378872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis work-up in prenatal medicine: the example of Down's syndrome].
    Winaver D
    Gynecol Obstet Fertil; 2005 Dec; 33(12):1058. PubMed ID: 16316771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.